This information is current as Inflammasome in Lung Endothelial Cells Hemorrhagic Shock Activation of NLRP 3

[1]  Y. Vodovotz,et al.  Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. , 2011, American journal of respiratory cell and molecular biology.

[2]  M. Lamkanfi.  Emerging inflammasome effector mechanisms , 2011, Nature Reviews Immunology.

[3]  E. Mazzon,et al.  Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. , 2011, Biochemical pharmacology.

[4]  J. Tschopp,et al.  NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.

[5]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[6]  Y. Vodovotz,et al.  Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  A. Sauaia,et al.  HMGB1 IS MARKEDLY ELEVATED WITHIN 6 HOURS OF MECHANICAL TRAUMA IN HUMANS , 2009, Shock.

[8]  Y. Vodovotz,et al.  Interacting Neuroendocrine and Innate and Acquired Immune Pathways Regulate Neutrophil Mobilization from Bone Marrow following Hemorrhagic Shock1 , 2009, The Journal of Immunology.

[9]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[10]  T. Billiar,et al.  Early events in the recognition of danger signals after tissue injury , 2008, Journal of leukocyte biology.

[11]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[12]  K. Tracey,et al.  Hemorrhagic Shock Induces NAD(P)H Oxidase Activation in Neutrophils: Role of HMGB1-TLR4 Signaling1 , 2007, The Journal of Immunology.

[13]  E. Chavakis,et al.  A novel pathway of HMGB1‐mediated inflammatory cell recruitment that requires Mac‐1‐integrin , 2007, The EMBO journal.

[14]  Y. Vodovotz,et al.  Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[15]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[16]  M. Lotze,et al.  Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells1 , 2005, The Journal of Immunology.

[17]  I. Douglas,et al.  HMGB1 contributes to the development of acute lung injury after hemorrhage. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[18]  K. Tracey,et al.  The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion , 2005, The Journal of experimental medicine.

[19]  M. Lotze,et al.  Addicted to Death: Invasive Cancer and the Immune Response to Unscheduled Cell Death , 2005, Journal of immunotherapy.

[20]  C. Roussos,et al.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill , 2004, Intensive Care Medicine.

[21]  U. Andersson,et al.  Mini‐review: The nuclear protein HMGB1 as a proinflammatory mediator , 2004, European journal of immunology.

[22]  E. Abraham,et al.  Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein* , 2004, Journal of Biological Chemistry.

[23]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Frey,et al.  TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. , 2003, The Journal of clinical investigation.

[25]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[26]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[27]  M. Freichel,et al.  Impairment of Store-Operated Ca2+ Entry in TRPC4−/− Mice Interferes With Increase in Lung Microvascular Permeability , 2002, Circulation research.

[28]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[29]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[30]  M. J. Cotter,et al.  A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. , 2001, The American journal of pathology.

[31]  B. Babior.  The NADPH Oxidase of Endothelial Cells , 2000, IUBMB life.

[32]  K. Tracey,et al.  High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.

[33]  L. Moldawer,et al.  ANTICYTOKINE THERAPIES FOR ACUTE INFLAMMATION AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: IL‐10 AND ISCHEMIA/REPERFUSION INJURY AS A NEW PARADIGM , 2000, Shock.

[34]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[35]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[36]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[37]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[38]  A. Al-Mehdi,et al.  Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.

[39]  J. Marshall,et al.  Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. , 1998, Journal of immunology.

[40]  S. Opal,et al.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.

[41]  R. Goris,et al.  Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. , 1995, Critical care medicine.

[42]  S. Lowry,et al.  Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis. , 1994, Circulatory shock.

[43]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[44]  R. Shenkar,et al.  Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. , 1994, American journal of respiratory cell and molecular biology.

[45]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[46]  R. Shenkar,et al.  Effects of hemorrhage on cytokine gene transcription. , 1993, Lymphokine and cytokine research.

[47]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[48]  E. Abraham,et al.  Effects of hemorrhage on interleukin-1 production. , 1988, Circulatory shock.

[49]  T. Petty,et al.  Adult respiratory distress syndrome: risk with common predispositions. , 1983, Annals of internal medicine.

[50]  K. Tracey,et al.  IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. , 2007, Journal of immunology.

[51]  K. Tracey,et al.  Targeting high mobility group box 1 as a late-acting mediator of inflammation. , 2003, Critical care medicine.

[52]  I. Chaudry,et al.  Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. , 1995, Cytokine.

[53]  A. Ellrodt,et al.  Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.